Compare Sumi Indo Kabel Tbk. (IKBI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sumi Indo Kabel Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Sumi Indo Kabel Tbk. trades at Rp565 (market cap 691.56B), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B). The key difference: Sumi Indo Kabel Tbk. is far larger — about 4.1× Brigit Biofarmaka Teknologi Tbk.'s market cap. Which is the better fit depends on your goals.
| IKBI | OBAT | |
|---|---|---|
Market Cap | 691.56B | 167.37B |
Indicative Equilibrium Price | 565 | 246 |
Indicative Equilibrium Volume | 3 | 24 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sumi Indo Kabel Tbk.
The Company was established on July 23, 1981 with its Head Office and Factory located in Tangerang, West Java. The Company was listed in JSX and SSX in 1990. On 1994 the Company changed status of the Company to become Foreign Capital Investment (PMA), right after participation of Sumitomo Electric Industries, Ltd., Japan which is one of the biggest in the world in cable industry and PT Perdanamulia Ekasakti.
Read more on IKBI →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
